Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.

• Contains 26 articles on such topics as management of locoregional melanoma; surgery for recurrent ovarian cancer; advances in pediatric cancer with big data: the Pediatric Cancer Data Commons; advanced imaging in gliomas; approach to minimal residual disease for acute myeloid leukemia; treatment options for HER2-expressing gastroesophageal cancers; and more.
• Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice.
• Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

Contemporary Management of Dermatofibrosarcoma Protuberans
Management of Locoregional Melanoma
Current Management of Intraductal Papillary Mucinous Neoplasms
Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy
Optimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung Cancer
Beyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to Resistance
Antibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application
Surgery for Recurrent Ovarian Cancer
Big Data in Pediatric Oncology: Hope, Hype, Reality
Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas
Diagnostic and Theranostic Opportunities in Neuro-Oncology
Updates on Revised Diagnostic Criteria and Targeted Therapies for Neurofibromatosis
Management of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell Transplantation
T-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth Watching
Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia
Role of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial Cancer
Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Patient Selection and Overview of Doublet and Triplet Therapy Data
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions
Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers
Current and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal Cancers
Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma
Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma